Cargando…
E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction
Mutations in cardiac myosin binding protein C (cMyBP-C) are prevalent causes of hypertrophic cardiomyopathy (HCM). Although HCM-causing truncation mutations in cMyBP-C are well studied, the growing number of disease-related cMyBP-C missense mutations remain poorly understood. Our objective was to de...
Autores principales: | De Lange, Willem J., Grimes, Adrian C., Hegge, Laura F., Spring, Alexander M., Brost, Taylor M., Ralphe, J. Carter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753599/ https://www.ncbi.nlm.nih.gov/pubmed/23980194 http://dx.doi.org/10.1085/jgp.201311018 |
Ejemplares similares
-
Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle
por: Kulikovskaya, Irina, et al.
Publicado: (2003) -
MyBP-C: one protein to govern them all
por: Heling, L. W. H. J., et al.
Publicado: (2020) -
Circulating S‐Glutathionylated cMyBP‐C as a Biomarker for Cardiac Diastolic Dysfunction
por: Zhou, Xiaoxu, et al.
Publicado: (2022) -
Molecular Modeling of Disease Causing Mutations in Domain C1 of cMyBP-C
por: Gajendrarao, Poornima, et al.
Publicado: (2013) -
cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca(2+)-handling abnormalities
por: De Lange, Willem J., et al.
Publicado: (2023)